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Despite the high prevalence of tuberculosis (TB) worldwide, pancreatic TB is rare. When present, pancreatic TB is frequently
associated with miliary TB, often in immunocompromised hosts. Pancreatic TB may present as a pancreatic abscess, acute or
chronic pancreatitis, and cystic or solid pancreatic masses. We present a case of an immunocompetent patient who presented
with two discrete pancreatic masses and was subsequently diagnosed with isolated pancreatic TB. This case suggests that clinicians
should have a heightened suspicion of pancreatic TB when faced with discrete pancreatic lesions, especially in patients from areas
where the infection is endemic. Such recognition may lead to appropriate diagnostic testing, and possible resolution of pancreatic
lesions with antituberculin therapy.
1.Introduction
Tuberculosis (TB) involving the pancreas is uncommon,
especially when present in immunocompetent hosts [1].
Often occurring in the setting of miliary TB or widely dis-
seminated disease; isolated primary pancreatic TB is ex-
tremelyrare[1, 2]. Pancreatic TB may present as a pancreatic
abscess, acute or chronic pancreatitis, and cystic or solid
pancreatic masses [1, 2]. We present a case of isolated pan-
creatic TB presenting as two discrete pancreatic masses in an
immunocompetent host.
2. Case Presentation
A 20-year-old African male, who recently emigrated from
Ghana, presented to the medical emergency room with
complaints of abdominal pain and nausea for nearly 2 weeks.
The patient stated that approximately 2 weeks ago he began
noticing dull, intermittent, midepigastric pain which was
neither alleviated nor aggravated by any factors. He also
admitted having nausea over the past 10 days, and admitted
having a 20-pound unintentional weight loss over the past
6 months. He denied any vomiting, hematemesis, melena,
fever, chills, night sweats, and cough. The patient stated
that he had previously been in good health and denied the
use of any medications. He denied the use of illicit drugs,
alcohol,andtobaccoandhadneverparticipatedinanysexual
activity. Family history was noncontributory, including the
absence of malignancy, or gastrointestinal disorders. Prior
to his arrival in the United States 4 weeks ago, puriﬁed
protein derivative (PPD) testing for tuberculosis yielded an
induration of less than 1centimeter (cm).
Physical examination was remarkable for mild mide-
pigastric tenderness without guarding or rigidity. Liver
transaminases and total bilirubin were within normal range;
however there was an increased alkaline phosphatase noted
to be 200U/L. Amylase and lipase levels were also within
normal range. Chest X-ray performed was negative for
any cardiopulmonary process, and lung ﬁelds were noted
to be clear. Computed tomography (CT) of the abdomen
performed revealed a complex cystic mass with thick-walled
irregular septations in head of the pancreas and extending
into the porta hepatis, suspicious for a cystic pancreatic
neoplasm (Figure 1). Also noted was another complex cystic2 Case Reports in Medicine
Figure 1: Acomplex cystic mass with thick-walled irregular septa-
tions indenting the head of the pancreas (arrow), mimicking the
appearance of a cystic neoplasm.
 
      
Figure 2: A complex cystic lesion with an internal septation in the
splenic porta lying between the tail of the pancreas and the spleen
(arrow).
lesion with an internal septation in the splenic porta lying
between the tail of the pancreas and the spleen (Figure 2).
Endoscopic ultrasound (EUS) with ﬁne needle aspira-
tion (FNA) of the pancreatic head mass was performed.
Sonographically, there was a 3cm irregular mass within the
head of the pancreas extending into the porta hepatis. On-
site cytologic and histopathologic evaluation of the biopsy
specimen revealed the presence of lymphohistiocytic aggre-
gates suggestive of granulomatous inﬂammation with no
evidence of malignancy (Figure 3). Although smears for acid
fast bacilli were negative, a culture of the specimen obtained
was remarkable for Mycobacterium tuberculosis.
Given the diagnosis of pancreatic TB, testing for human
immunodeﬁciency virus, a repeat PPD and interferon-γ
release assay for TB were performed; all yielding negative
results. The patient was started on antituberculin ther-
apy with isoniazid, rifampin, pyrazinamide, and ethambu-
tol. The patient reported improvement of symptoms after
3 months of therapy. Repeat imaging of the abdomen per-
formed 3months after the initiation of antituberculin ther-
apy revealed complete resolution of the two pancreatic
masses, and antituberculin therapy was discontinued after a
6-month duration.
Figure 3: Cell block prepared from the ﬁne needle aspirate of the
mass seen in the pancreatic head. Note the appearance of lympho-
histiocytic aggregates suggestive of granulomatous inﬂammation.
3. Discussion
Tuberculosis (TB) is a multisystemic infectious disease
caused by various strains of mycobacteria, usually Mycobac-
terium tuberculosis. It is estimated that nearly 9.7 million
cases of TB are reported annually; with the highest incidence
of infection occurring in Asia, South America, eastern
Europe,andmostsub-SaharanAfricancountries[3].Despite
a declining incidence of TB in the United States, there were
approximately11,200newcasesofTBreportedbytheUnited
States Center for Disease Control and Prevention (CDC) in
2010 [4]. Although pulmonary TB is the most common pre-
sentation of disease; extrapulmonary TB (EPTB) accounts
for nearly 20percent of all cases of TB in immunocompetent
hosts,andnearly 50percentofallcasesofTBinpatients with
human immunodeﬁciency virus [5, 6].
By deﬁnition, EPTB describes the occurrence of TB at
sitesotherthanthelung.Thetermmustnotbeconfusedwith
miliary TB, as this refers to pulmonary involvement with
EPTB, and not EPTB in isolation. EPTB can occur in almost
any organ system, with the most common sites of infection
being the lymph nodes, pleura, genitourinary system, and
bone [5, 6]. Abdominal TB is the sixth most common site for
EPTBandincludesinfectionanywhereinthegastrointestinal
tract, peritoneum, and intra-abdominal organs such as the
spleen, liver, and pancreas [6].
Pancreatic TB is rare, with an incidence reported to be
less than 4.7percent worldwide [7]. Isolated pancreatic TB is
extremely uncommon, with pancreatic involvement usually
occurring in the setting of miliary or widely disseminated
TB; often in immunocompromised hosts [1, 5–7]. Infection
of the pancreas is thought to occur by direct extension to
the organ via lymphatic or hematogenous spread, or by
reactivation of previous TB infection [5–7]. Pancreatic TB
may present as pancreatic abscesses, acute or chronic pan-
creatitis, gastrointestinal bleeding, and in rare cases, discrete
pancreatic masses mimicking malignancy [5, 8–10].
The clinical presentation of pancreatic TB is often insid-
ious, with nonspeciﬁc constitutional symptoms occurring
frequently [5]. In a study by Saluja et al., the three most
common presenting complaints in patients found to have
pancreatic TB were abdominal pain, jaundice, and weightCase Reports in Medicine 3
loss [11]. Individuals infected with pancreatic TB may also
present with fever, gastrointestinal hemorrhage secondary
to splenic vein thrombosis, and anorexia [11]. If pancreatic
TB is suspected, preliminary testing such as tuberculin skin
testing and an interferon-γ release assay for TB may be
negative in patients. Sharma et al. suggest that the sensitivity
of tuberculin skin testing in patients with abdominal tuber-
culosis may range from 58 to 100percent [5]. With the wide-
ranging sensitivities of TB screening modalities and an often
nonspeciﬁc and varied clinical presentation of pancreatic
TB; diagnosis of infection relies heavily on radiologic and
histopathologic ﬁndings.
Ultrasonography or computed tomography (CT) are
often ﬁrst-line diagnostic modalities in patients presenting
with signs of pancreatic pathology [1, 5]. Ultrasonography
and CT may reveal both hypodense and hyperechoic lesions,
typically found in the head of the pancreas. The ﬁndings
of these solid or cystic lesions are however nonspeciﬁc,
as pancreatic adenocarcinomas, cystadenocarcinomas, and
pancreatic psuedocysts often have similar appearances [11].
D’cruz et al. further suggest that there is no radiographical
diﬀerence between cystic neoplasm of the pancreas and
pancreatic TB abscess formation, as both present as septated
masses with surrounding hypodense lymphadenopathy [12].
As the initial radiographic and clinical presentation of
isolated pancreatic TB may mimic malignancy; histologic
evaluationofthelesionisessentialfordiagnosisofpancreatic
TB [12, 13].
Techniques for pancreatic biopsy include CT or
ultrasound-guided percutaneous biopsy, surgical biopsy, or
endoscopic ultrasound-(EUS-) guided ﬁne needle aspiration
(FNA) [1]. The American Joint Commission on Cancer
(AJCC) recommends EUS-FNA as the diagnostic modality
of choice in patients with pancreatic masses and has found it
to be the most sensitive and speciﬁc method for identifying
the etiology of pancreatic masses [1]. The presence of
on-site cytology is imperative in the diagnosis of pancreatic
TB, as the immediate interpretation of the specimen will
allow clinicians to request appropriate cultures [1]. The
presence of on-site cytology has also been shown to increase
the diagnostic yield of FNA by up to 15percent and may
also decrease potential complications by avoiding the need
for multiple needle passes once initial diagnostic tissue
is procured [1, 14]. Cytologic interpretation of biopsy
specimens may reveal the presence of granulomatous in-
ﬂammation, with the presence of aggregates of epitheloid
histiocytes, plasma cells, and lymphocytes [9]. Acid fast
bacilli are commonly not seen with FNA. In a study by
Farar et al., nearly 40percent of patients with abdominal
TB had staining that was negative for acid fast bacilli [15].
Clinicians should be cognizant of the relatively low yield of
FNA specimens to reveal acid fast bacilli and thus culture
the specimen for evidence of Mycobacterium tuberculosis
[9, 15]. Bacterial culture, although requiring a prolonged
incubation, has proven to be the most speciﬁc diagnostic
modality to reveal pancreatic TB [9].
Once the diagnosis of pancreatic TB has been made,
standard antituberculin therapy appears to be successful in
management of this infection. A minimum of 6months
of antituberculin therapy is often indicated to achieve
resolution of pancreatic lesions and alleviation of symp-
toms. Follow-up CT imaging after treatment may reveal
the complete resolution of pancreatic lesions secondary to
tuberculosis and may guide clinicians regarding duration of
therapy [16].
4. Conclusion
Isolated pancreatic TB is extremely rare and may present as
discrete pancreatic masses. As the clinical and radiographic
presentation may mimic malignancy; clinicians should have
heightened suspicion of infectious processes such as TB as
a potential etiology of such masses [11]. Furthermore, TB
should be considered as a cause of any suspicious pancreatic
lesion, especially in patients from areas where the infection
is endemic [11]. Clinical awareness of pancreatic TB may
guide clinicians to appropriate diagnostic studies and man-
agement; which may lead to alleviation of symptoms and
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